Gemelli Biotech

Gemelli Biotech

  • Founded: 2018
  • Location: Los Angeles, CA
  • Employee range: 11 - 50
  • Funding: $19M A Jun 2022
  • Investors: Blue Ox Healthcare Partners, Cedars-Sinai, Carolina Angel Network, CerraCap Ventures

job board

Short description:

Novel diagnostics and therapeutics for the human microbiome, gut gas profile

Drug notes:

Contact us to add description:

Long description:

Gemelli Biotech is developing and distributing precision diagnostics for gastrointestinal (GI) diseases. The GI tract is home to many microorganisms collectively referred to as the microbiome, the composition of which is linked to various diseases. Gemelli is leveraging microbiome biological discoveries to provide non-invasive precision diagnostics such that clinicians can detect scientifically validated biomarkers in patients and optimally treat GI diseases. This includes Gemelli’s blood test, ibs-smart, that measures antibody levels elevant in patients with irritable bowel syndrome and trio-smart, a breath test that provides a complete profile of the primary fermented gases in the microbiome.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy